Elite Research MK-777 60 caps

Overview

Elite Research MK-777 60 caps is a specialized research chemical featuring MK-777, also known as Acetamoren. This product is formulated as an oral ghrelin receptor agonist, providing 60 capsules for controlled research protocols. Each capsule delivers a precise dosage, making it suitable for advanced studies in a laboratory setting.

Composition & Ingredients

• MK-777 (Acetamoren) – 10 mg
• Serving Size: 1 capsule
• Servings Per Container: 60

How It Works

MK-777 functions as a non-peptide ghrelin receptor agonist, activating the GHSR1a receptor found in the pituitary and hypothalamus. This activation stimulates the endogenous production and pulsatile release of Growth Hormone (GH) and subsequently, Insulin-like Growth Factor-1 (IGF-1). By mimicking the action of ghrelin, it promotes a physiological pattern of GH secretion, which can lead to various downstream effects on cellular processes.

Benefits

• Supports lean body mass in research subjects
• May influence sleep architecture, including REM and deep sleep
• Contributes to sustained elevation of IGF-1 levels
• Can impact appetite regulation, which may be relevant for specific research objectives

How to Use

As explicitly stated on the label, this product is a “RESEARCH CHEMICAL ONLY – NOT FOR HUMAN CONSUMPTION.” Specific directions for human use are not provided. Researchers should adhere strictly to established laboratory protocols and safety guidelines for the handling and application of research chemicals.

Useful Tips

• Store the product in a cool, dry place away from direct sunlight to maintain stability.
• Ensure proper laboratory safety procedures are followed when handling this research chemical.
• Maintain accurate records of usage and experimental conditions for reliable research outcomes.
• Consider the potential impact on appetite when designing research protocols, as ghrelin agonism can influence hunger signals.

Scientific References

• Chapman IM et al., J Clin Endocrinol Metab. 1996
• Murphy MG et al., J Clin Endocrinol Metab. 1998
• Nass R et al., Ann Intern Med. 2008